Séverine Vermeire

KU Leuven (BE)

Research Areas

Discover Papers by Séverine Vermeire

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

164

Publications

2385

Citations

111155

i10-index

773

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
Toward an Integrated Clinical, Molecular and Serol...	2005	3370
Genome-wide association defines more than 30 disti...	2008	2623
Genome-wide meta-analysis increases to 71 the numb...	2010	2574
Influence of Immunogenicity on the Long-Term Effic...	2003	2015
A decrease of the butyrate-producing species <i>Ro...	2013	1881
Ustekinumab as Induction and Maintenance Therapy f...	2016	1770
Tofacitinib as Induction and Maintenance Therapy f...	2017	1690
Second European evidence-based consensus on the di...	2012	1549
Early combined immunosuppression or conventional m...	2008	1234
The intestinal barrier: a fundamental role in heal...	2017	1192

Publications

1.
Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Year: 2005Citations: 3370DOI: 10.1155/2005/269076
2.
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
Year: 2008Citations: 2623DOI: 10.1038/ng.175
3.
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
Year: 2010Citations: 2574DOI: 10.1038/ng.717
4.
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Year: 2003Citations: 2015DOI: 10.1056/nejmoa020888
5.
A decrease of the butyrate-producing species <i>Roseburia hominis</i> and <i>Faecalibacterium prausnitzii</i> defines dysbiosis in patients with ulcerative colitis
Year: 2013Citations: 1881DOI: 10.1136/gutjnl-2013-304833
6.
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
Year: 2016Citations: 1770DOI: 10.1056/nejmoa1602773
7.
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
Year: 2017Citations: 1690DOI: 10.1056/nejmoa1606910
8.
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Year: 2012Citations: 1549DOI: 10.1016/j.crohns.2012.09.002
9.
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial
Year: 2008Citations: 1234DOI: 10.1016/s0140-6736(08)60304-9
10.
The intestinal barrier: a fundamental role in health and disease
Year: 2017Citations: 1192DOI: 10.1080/17474124.2017.1343143

About Séverine Vermeire

Séverine Vermeire is a researcher with 2385 publications and 111155 citations. They are affiliated with KU Leuven. Their research focuses on . With an h-index of 164, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from Séverine Vermeire and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year